Diagnosis and management of chronic thromboembolic pulmonary hypertension (CTEPH) in sickle cell disease: A review

被引:1
|
作者
Hersi, Kadija [1 ,2 ]
Ramani, Gautam V. [3 ]
Law, Jennie Y. [4 ]
Sadek, Ahmed S. [5 ]
Vaidya, Anjali [5 ]
Gladwin, Mark T. [1 ]
Cassady, Steven J. [1 ]
机构
[1] Univ Maryland, Sch Med, Dept Med, Div Pulm & Crit Care Med, 110 S Paca St,2nd Floor, Baltimore, MD 21211 USA
[2] NIA, Natl Heart Lung & Blood Inst, Bethesda, MD USA
[3] Univ Maryland, Sch Med, Dept Med, Div Cardiol, Baltimore, MD USA
[4] Univ Maryland, Sch Med, Dept Med, Div Hematol & Oncol, Baltimore, MD USA
[5] Lewis Katz Sch Med Temple, Dept Med, Div Cardiol, Philadelphia, PA USA
关键词
balloon pulmonary angioplasty; hemolytic anemia; pulmonary thromboendarterectomy; THROMBOENDARTERECTOMY; ENDARTERECTOMY; HYDROXYUREA; ADULTS; ASSOCIATION; RIOCIGUAT; THERAPY; SOCIETY; PATIENT; DEATH;
D O I
10.1002/pul2.12362
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Pulmonary hypertension in sickle cell disease (SCD) is a complex phenomenon resulting from multiple overlapping etiologies, including pulmonary vasoconstriction in the setting of chronic hemolytic anemia, diastolic dysfunction, and chronic thromboembolic disease. The presence of pulmonary hypertension of any cause in SCD confers a significant increase in mortality risk. Evidence to guide the management of patients with sickle cell disease and chronic thromboembolic pulmonary hypertension (CTEPH) is scant and largely the realm of case reports and small case series. Centered on a discussion of a complex young patient with hemoglobin hemoglobin SC who ultimately underwent treatment with pulmonary thromboendarterectomy, we review the available literature to guide management and discuss and overview of treatment of CTEPH in SCD, considering the unique considerations and challenges facing patients suffering from this multisystem disease.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Thrombophilic markers in patients with chronic thromboembolic pulmonary hypertension (CTEPH)
    Batorova, A.
    Simkova, I
    Jankovicova, D.
    Prigancova, T.
    Morongova, A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 866 - 866
  • [32] Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Diagnosed During Pregnancy
    Hegab, Sara
    Patel, Niral
    Mendez, Michael
    Awdish, Rana
    Cajigas, Hector
    CHEST, 2015, 148 (04)
  • [33] Chronic thromboembolic pulmonary Hypertension (CTEPH) 2014 A Position Paper
    Wilkens, H.
    Lang, I.
    Blankenburg, T.
    Grohe, C.
    Guth, S.
    Held, M.
    Klepetko, W.
    Konstantinides, S.
    Kramm, T.
    Krueger, U.
    Lankeit, M.
    Schaefers, H. J.
    Seyfarth, H. J.
    Mayer, E.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2014, 139 : S155 - S165
  • [34] Epidemiology of chronic thromboembolic pulmonary hypertension (CTEPH) in the Czech Republic
    Jansa, Pavel
    Ambroz, David
    Kuhn, Matyas
    Dytrych, Vladimir
    Linhart, Ales
    Lindner, Jaroslav
    Muller, Audrey
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [35] Chronic Thromboembolic Pulmonary Hypertension: Epidemiology, Diagnosis, and Management
    Yandrapalli, Srikanth
    Tariq, Sohaib
    Kumar, Jessica
    Aronow, Wilbert S.
    Malekan, Ramin
    Frishman, William H.
    Lanier, Gregg M.
    CARDIOLOGY IN REVIEW, 2018, 26 (02) : 62 - 72
  • [36] Current diagnosis and management of chronic thromboembolic pulmonary hypertension
    Lang, I. M.
    Simonneau, G.
    Pepke-Zaba, J.
    Mayer, E.
    Delcroix, M.
    EUROPEAN HEART JOURNAL, 2010, 31 : 916 - 916
  • [37] To See the Wood for the Trees: Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
    Seheult, J.
    O'Brien, M. E.
    Morgan, R. K.
    Costello, R. W.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2011, 180 : S426 - S427
  • [38] Epidemiology of chronic thromboembolic pulmonary hypertension (CTEPH) in the Czech Republic
    Jansa, Pavel
    Ambroz, David
    Kuhn, Matyas
    Dytrych, Vladimir
    Aschermann, Michael
    Cerny, Vladimir
    Gressin, Virginie
    Heller, Samuel
    Kunstyr, Jan
    Siranec, Michal
    Song, Ci
    Linhart, Ales
    Lindner, Jaroslav
    Muller, Audrey
    PULMONARY CIRCULATION, 2022, 12 (01)
  • [39] Ambrisentan for treatment of inoperable chronic thromboembolic pulmonary hypertension (CTEPH)
    Escribano-Subias, Pilar
    Bendjenana, Hakim
    Curtis, Paula S.
    Lang, Irene
    Noordegraaf, Anton Vonk
    PULMONARY CIRCULATION, 2019, 9 (02)
  • [40] Potential Contribution of Pulmonary Thromboembolic Disease in Pulmonary Hypertension in Sickle Cell Disease
    Nouraie, Mehdi
    Zhang, Xu
    Srisuwananukorn, Andrew
    Machado, Roberto F.
    Gordeuk, Victor R.
    Gladwin, Mark T.
    Saraf, Santosh
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2020, 17 (07) : 899 - 901